Loading...
•
Sep 30, 2020
Astrana Health Q3 2020 Earnings Report
Apollo Medical Holdings, Inc. reported consolidated financial results with revenue increase, net income growth, and raised full-year guidance.
Key Takeaways
ApolloMed reported a strong Q3 2020 with a 15% increase in total revenue to $180.1 million and a 137% increase in net income to $25.4 million. Net income attributable to ApolloMed increased to $16.7 million. The company also raised its full-year 2020 net income, EBITDA, and adjusted EBITDA guidance due to a net shared savings settlement of $13.3 million.
Q3 total revenue increased by 15% year-over-year to $180.1 million.
Q3 net income increased by 137% year-over-year to $25.4 million.
Net income attributable to ApolloMed increased to $16.7 million.
Full-year 2020 net income, EBITDA, and adjusted EBITDA guidance were raised.
Revenue by Segment
Forward Guidance
ApolloMed raised its full-year 2020 net income guidance from a range of $100.0 million to $110.0 million to a range of $110.0 million to $120.0 million. The company expects total revenue between $665.0 million and $675.0 million.
Positive Outlook
- Maintaining total revenue between $665.0 million and $675.0 million.
- Raising net income from a range of $100.0 million to $110.0 million to a range of $110.0 million to $120.0 million.
- Raising EBITDA from a range of $155.0 million to $167.0 million to a range of $182.0 million to $194.0 million.
- Raising adjusted EBITDA from a range of $75.0 million to $90.0 million to a range of $97.0 million to $112.0 million.
- Anticipate ending 2020 on a strong note as a result of the additional revenue contributions from the acquisitions made last year as well as organic capitation revenue growth.
Challenges Ahead
- Global pandemic continuing to cast a shadow over 2020
- COVID-19 has had a devastating impact on the individuals and families within our communities.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...